314 related articles for article (PubMed ID: 23383362)
1. Diagnosis and management of bacterial infections in decompensated cirrhosis.
Pleguezuelo M; Benitez JM; Jurado J; Montero JL; De la Mata M
World J Hepatol; 2013 Jan; 5(1):16-25. PubMed ID: 23383362
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
[TBL] [Abstract][Full Text] [Related]
3. EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1018-24. PubMed ID: 26793843
[TBL] [Abstract][Full Text] [Related]
4. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
[TBL] [Abstract][Full Text] [Related]
6. The value of ascitic neutrophil gelatinase-associated lipocalin in decompensated liver cirrhosis with spontaneous bacterial peritonitis.
Liu H; Zhu P; Nie C; Ye Q; Gao Y; Liu H; Pang G; Han T
J Clin Lab Anal; 2020 Jun; 34(6):e23247. PubMed ID: 32100329
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
[TBL] [Abstract][Full Text] [Related]
8. Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis.
Garcia-Tsao G
Dig Dis; 2016; 34(4):382-6. PubMed ID: 27170392
[TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
10. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
Reuken PA; Pletz MW; Baier M; Pfister W; Stallmach A; Bruns T
Aliment Pharmacol Ther; 2012 May; 35(10):1199-208. PubMed ID: 22449290
[TBL] [Abstract][Full Text] [Related]
11. Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies.
Liu J; Gao Y; Wang X; Qian Z; Chen J; Huang Y; Meng Z; Lu X; Deng G; Liu F; Zhang Z; Li H; Zheng X
Yonsei Med J; 2020 Feb; 61(2):145-153. PubMed ID: 31997623
[TBL] [Abstract][Full Text] [Related]
12. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi.
Maraolo AE; Buonomo AR; Zappulo E; Scotto R; Pinchera B; Gentile I
Rev Recent Clin Trials; 2019; 14(2):129-135. PubMed ID: 30514194
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies and emergence of multiresistant bacterial strains.
Salerno F; Cazzaniga M
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S45-51. PubMed ID: 20865474
[TBL] [Abstract][Full Text] [Related]
14. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
[TBL] [Abstract][Full Text] [Related]
15. The impact of bacterial infections on survival of patients with decompensated cirrhosis.
Strauss E
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):7-19. PubMed ID: 24516916
[TBL] [Abstract][Full Text] [Related]
16. [Bacterial infections in liver cirrhosis].
Papp M; Farkas A; Udvardy M; Tornai I
Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
[TBL] [Abstract][Full Text] [Related]
18. Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention.
Dever JB; Sheikh MY
Aliment Pharmacol Ther; 2015 Jun; 41(11):1116-31. PubMed ID: 25819304
[TBL] [Abstract][Full Text] [Related]
19. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.
Li H; Wieser A; Zhang J; Liss I; Markwardt D; Hornung R; Neumann-Cip AC; Mayerle J; Gerbes A; Steib CJ
Eur J Clin Invest; 2020 Feb; 50(2):e13198. PubMed ID: 31886517
[TBL] [Abstract][Full Text] [Related]
20. Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections.
Ding X; Yu Y; Chen M; Wang C; Kang Y; Lou J
BMC Infect Dis; 2019 May; 19(1):463. PubMed ID: 31122192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
